Bank of New York Mellon’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Sell |
66,712
-6,926
| -9% | -$129K | ﹤0.01% | 2990 |
|
|
2025
Q1 | $1.34M | Buy |
73,638
+748
| +1% | +$13.6K | ﹤0.01% | 2877 |
|
|
2024
Q4 | $1.59M | Sell |
72,890
-125
| -0.2% | -$2.73K | ﹤0.01% | 2853 |
|
|
2024
Q3 | $2M | Sell |
73,015
-7,920
| -10% | -$217K | ﹤0.01% | 2738 |
|
|
2024
Q2 | $2.09M | Buy |
80,935
+72,509
| +861% | +$1.88M | ﹤0.01% | 2769 |
|
|
2024
Q1 | $253K | Buy |
+8,426
| New | +$253K | ﹤0.01% | 3845 |
|
|
2023
Q3 | – | Sell |
-3,775
| Closed | -$45.8K | – | 4353 |
|
|
2023
Q2 | $45.8K | Sell |
3,775
-308
| -8% | -$3.74K | ﹤0.01% | 4180 |
|
|
2023
Q1 | $51.9K | Buy |
4,083
+3,080
| +307% | +$39.2K | ﹤0.01% | 4187 |
|
|
2022
Q4 | $6.34K | Sell |
1,003
-2
| -0.2% | -$13 | ﹤0.01% | 4439 |
|
|
2022
Q3 | $23K | Hold |
1,005
| – | – | ﹤0.01% | 4432 |
|
|
2022
Q2 | $19K | Sell |
1,005
-4,324
| -81% | -$81.7K | ﹤0.01% | 4497 |
|
|
2022
Q1 | $247K | Sell |
5,329
-3
| -0.1% | -$139 | ﹤0.01% | 4120 |
|
|
2021
Q4 | $378K | Buy |
5,332
+101
| +2% | +$7.16K | ﹤0.01% | 3963 |
|
|
2021
Q3 | $609K | Buy |
5,231
+267
| +5% | +$31.1K | ﹤0.01% | 3689 |
|
|
2021
Q2 | $777K | Buy |
4,964
+809
| +19% | +$127K | ﹤0.01% | 3558 |
|
|
2021
Q1 | $788K | Sell |
4,155
-77
| -2% | -$14.6K | ﹤0.01% | 3465 |
|
|
2020
Q4 | $531K | Buy |
4,232
+138
| +3% | +$17.3K | ﹤0.01% | 3587 |
|
|
2020
Q3 | $446K | Sell |
4,094
-69
| -2% | -$7.52K | ﹤0.01% | 3550 |
|
|
2020
Q2 | $500K | Buy |
4,163
+244
| +6% | +$29.3K | ﹤0.01% | 3474 |
|
|
2020
Q1 | $394K | Sell |
3,919
-10
| -0.3% | -$1.01K | ﹤0.01% | 3484 |
|
|
2019
Q4 | $953K | Buy |
3,929
+186
| +5% | +$45.1K | ﹤0.01% | 3269 |
|
|
2019
Q3 | $614K | Buy |
3,743
+436
| +13% | +$71.5K | ﹤0.01% | 3421 |
|
|
2019
Q2 | $781K | Buy |
3,307
+624
| +23% | +$147K | ﹤0.01% | 3362 |
|
|
2019
Q1 | $707K | Buy |
2,683
+1,698
| +172% | +$447K | ﹤0.01% | 3377 |
|
|
2018
Q4 | $90K | Buy |
+985
| New | +$90K | ﹤0.01% | 3973 |
|